Alice M Graham1, Jerod M Rasmussen2, Marc D Rudolph1, Christine M Heim3, John H Gilmore4, Martin Styner4, Steven G Potkin5, Sonja Entringer6, Pathik D Wadhwa2, Damien A Fair7, Claudia Buss8. 1. Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, Oregon. 2. Development, Health and Disease Research Program, University of California, Irvine, Irvine, California. 3. Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Medical Psychology, Berlin, Germany; Department of Biobehavioral Health, Pennsylvania State University, University Park, Pennsylvania. 4. Department of Psychiatry, University of North Carolina, Chapel Hill, North Carolina. 5. Department of Psychiatry and Human Behavior, University of California, Irvine, Irvine, California. 6. Development, Health and Disease Research Program, University of California, Irvine, Irvine, California; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Medical Psychology, Berlin, Germany. 7. Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, Oregon; Advanced Imaging Research Center, Oregon Health & Science University, Portland, Oregon. 8. Development, Health and Disease Research Program, University of California, Irvine, Irvine, California; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Medical Psychology, Berlin, Germany. Electronic address: claudia.buss@charite.de.
Abstract
BACKGROUND: Maternal inflammation during pregnancy increases the risk for offspring psychiatric disorders and other adverse long-term health outcomes. The influence of inflammation on the developing fetal brain is hypothesized as one potential mechanism but has not been examined in humans. METHODS: Participants were adult women (N = 86) who were recruited during early pregnancy and whose offspring were born after 34 weeks' gestation. A biological indicator of maternal inflammation (interleukin-6) that has been shown to influence fetal brain development in animal models was quantified serially in early, mid-, and late pregnancy. Structural and functional brain magnetic resonance imaging scans were acquired in neonates shortly after birth. Infants' amygdalae were individually segmented for measures of volume and as seeds for resting state functional connectivity. At 24 months of age, children completed a snack delay task to assess impulse control. RESULTS: Higher average maternal interleukin-6 concentration during pregnancy was prospectively associated with larger right amygdala volume and stronger bilateral amygdala connectivity to brain regions involved in sensory processing and integration (fusiform, somatosensory cortex, and thalamus), salience detection (anterior insula), and learning and memory (caudate and parahippocampal gyrus). Larger newborn right amygdala volume and stronger left amygdala connectivity were in turn associated with lower impulse control at 24 months of age, and mediated the association between higher maternal interleukin-6 concentrations and lower impulse control. CONCLUSIONS: These findings provide new evidence in humans linking maternal inflammation during pregnancy with newborn brain and emerging behavioral phenotypes relevant for psychiatric disorders. A better understanding of intrauterine conditions that influence offspring disease susceptibility is warranted to inform targeted early intervention and prevention efforts.
BACKGROUND: Maternal inflammation during pregnancy increases the risk for offspring psychiatric disorders and other adverse long-term health outcomes. The influence of inflammation on the developing fetal brain is hypothesized as one potential mechanism but has not been examined in humans. METHODS: Participants were adult women (N = 86) who were recruited during early pregnancy and whose offspring were born after 34 weeks' gestation. A biological indicator of maternal inflammation (interleukin-6) that has been shown to influence fetal brain development in animal models was quantified serially in early, mid-, and late pregnancy. Structural and functional brain magnetic resonance imaging scans were acquired in neonates shortly after birth. Infants' amygdalae were individually segmented for measures of volume and as seeds for resting state functional connectivity. At 24 months of age, children completed a snack delay task to assess impulse control. RESULTS: Higher average maternal interleukin-6 concentration during pregnancy was prospectively associated with larger right amygdala volume and stronger bilateral amygdala connectivity to brain regions involved in sensory processing and integration (fusiform, somatosensory cortex, and thalamus), salience detection (anterior insula), and learning and memory (caudate and parahippocampal gyrus). Larger newborn right amygdala volume and stronger left amygdala connectivity were in turn associated with lower impulse control at 24 months of age, and mediated the association between higher maternal interleukin-6 concentrations and lower impulse control. CONCLUSIONS: These findings provide new evidence in humans linking maternal inflammation during pregnancy with newborn brain and emerging behavioral phenotypes relevant for psychiatric disorders. A better understanding of intrauterine conditions that influence offspring disease susceptibility is warranted to inform targeted early intervention and prevention efforts.
Authors: M D De Bellis; B J Casey; R E Dahl; B Birmaher; D E Williamson; K M Thomas; D A Axelson; K Frustaci; A M Boring; J Hall; N D Ryan Journal: Biol Psychiatry Date: 2000-07-01 Impact factor: 13.382
Authors: B F Sparks; S D Friedman; D W Shaw; E H Aylward; D Echelard; A A Artru; K R Maravilla; J N Giedd; J Munson; G Dawson; S R Dager Journal: Neurology Date: 2002-07-23 Impact factor: 9.910
Authors: Kate Walsh; Clare A McCormack; Rachel Webster; Anita Pinto; Seonjoo Lee; Tianshu Feng; H Sloan Krakovsky; Sinclaire M O'Grady; Benjamin Tycko; Frances A Champagne; Elizabeth A Werner; Grace Liu; Catherine Monk Journal: Proc Natl Acad Sci U S A Date: 2019-10-14 Impact factor: 11.205
Authors: Jerod M Rasmussen; Alice M Graham; Sonja Entringer; John H Gilmore; Martin Styner; Damien A Fair; Pathik D Wadhwa; Claudia Buss Journal: Neuroimage Date: 2018-04-11 Impact factor: 6.556
Authors: Julia E Morgan; Steve S Lee; Nicole E Mahrer; Christine M Guardino; Elysia Poggi Davis; Madeleine U Shalowitz; Sharon L Ramey; Christine Dunkel Schetter Journal: Dev Psychobiol Date: 2020-05-22 Impact factor: 3.038
Authors: Ami R Zota; Ruth J Geller; Laura E Romano; Kimberly Coleman-Phox; Nancy E Adler; Emily Parry; Miaomiao Wang; June-Soo Park; Angelo F Elmi; Barbara A Laraia; Elissa S Epel Journal: Environ Int Date: 2018-03-10 Impact factor: 9.621
Authors: Jing Yu; Akhgar Ghassabian; Zhen Chen; Risë B Goldstein; Mady Hornig; Stephen L Buka; Jill M Goldstein; Stephen E Gilman Journal: Brain Behav Immun Date: 2020-09-10 Impact factor: 7.217